Isolation of HIV NAbs from a nonimmune yeast-display library of scFv antibodies
从 scFv 抗体非免疫酵母展示文库中分离 HIV NAb
基本信息
- 批准号:7541768
- 负责人:
- 金额:$ 23.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-01-01 至 2011-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAntibodiesAntibody AffinityAntigensB-LymphocytesBacteriophagesBiological AssayDataDiversity LibraryEngineeringEnzyme-Linked Immunosorbent AssayEpitopesExhibitsGenerationsGlycoproteinsGoalsHIVHIV AntibodiesHIV Envelope Protein gp120HumanHuman Herpesvirus 4ImmuneImmunoglobulin FragmentsImmunoglobulin GKineticsLaboratoriesLibrariesMediatingMethodsMonoclonal AntibodiesMusMutagenesisNeutralization TestsPacific NorthwestPeptidesProteinsReagentResearchResearch PersonnelRoleSaccharomyces cerevisiaeScreening procedureSourceSurfaceSystemTechniquesTestingVirionYeastsantibody engineeringantigen bindinggp160improvedinsightneutralizing antibodynovelvaccine development
项目摘要
DESCRIPTION (provided by applicant): We will isolate anti-HIV neutralizing antibodies (NAbs) from a yeast-displayed library of human nonimmune scFv antibodies. Developed at Pacific Northwest National Laboratory, the PNNL scFv library is a high diversity library which has been used by numerous investigators to generate high-quality, high-affinity scFv antibodies to a myriad of protein antigens. The yeast display platform is also ideal for engineering scFv antibodies by affinity maturation through random mutagenesis. We will perform selections on the PNNL scFv library using HIV glycoprotein 140 (gp140), gp120- and gp41-derived peptides, and intact virions. We will introduce a novel method to secrete soluble biotinylated scFv for direct screening for neutralization of HIV. NAbs isolated from this library will then be subjected to affinity maturation to improve the breadth and potency of neutralization. Affinity matured NAbs, which vary in overall affinity as well as in their kinetic on- and off-rates, will be compared to their parental NAb for neutralization of a diverse panel of HIV isolates. This proposal will provide insights into two key questions: 1) can anti-HIV neutralizing scFv antibodies be isolated from a nonimmune library of human scFv antibodies; and 2) can the breath and potency of neutralization by these scFv be improved upon by improving their on-rates, off-rates, and affinities. These studies will identify new anti-HIV neutralizing antibodies and their epitopes as well as provide useful data for selection and engineering of NAbs isolated from any source.
描述(由申请人提供):我们将从酵母展示的人非免疫scFv抗体文库中分离抗HIV中和抗体(NAb)。PNNL scFv文库是由太平洋西北国家实验室开发的高多样性文库,已被许多研究人员用于产生针对无数蛋白质抗原的高质量、高亲和力scFv抗体。酵母展示平台对于通过随机诱变的亲和力成熟工程化scFv抗体也是理想的。我们将使用HIV糖蛋白140(gp 140)、gp 120和gp 41衍生肽以及完整病毒粒子对PNNL scFv文库进行选择。我们将介绍一种新的方法来分泌可溶性生物素化的单链抗体,用于直接筛选中和HIV。然后将从该文库分离的NAb进行亲和力成熟以提高中和的广度和效力。亲和力成熟的NAb(其总体亲和力以及其动力学结合和解离速率不同)将与其亲本NAb进行比较,以中和多种HIV分离株。该提议将提供对两个关键问题的见解:1)抗HIV中和scFv抗体能否从人scFv抗体的非免疫文库中分离;和2)这些scFv的中和的呼吸和效力能否通过改善它们的结合速率、解离速率和亲和力来改善。这些研究将鉴定新的抗HIV中和抗体及其表位,并为从任何来源分离的NAb的选择和工程化提供有用的数据。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Flow cytometry-based methods for assessing soluble scFv activities and detecting antigens in solution.
- DOI:10.1002/bit.22607
- 发表时间:2010-04-01
- 期刊:
- 影响因子:3.8
- 作者:Gray, Sean A.;Weigel, Kris M.;Miller, Keith D.;Ndung'u, Joseph;Buscher, Philippe;Tran, Thao;Baird, Cheryl;Cangelosi, Gerard A.
- 通讯作者:Cangelosi, Gerard A.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sean Alex Gray其他文献
Sean Alex Gray的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sean Alex Gray', 18)}}的其他基金
Evaluation of a Next Generation SchistoShield Vaccine
下一代 SchistoShield 疫苗的评估
- 批准号:
10761529 - 财政年份:2023
- 资助金额:
$ 23.88万 - 项目类别:
Isolation of HIV NAbs from a nonimmune yeast-display library of scFv antibodies
从 scFv 抗体非免疫酵母展示文库中分离 HIV NAb
- 批准号:
7418891 - 财政年份:2007
- 资助金额:
$ 23.88万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 23.88万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 23.88万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 23.88万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 23.88万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 23.88万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 23.88万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 23.88万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 23.88万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 23.88万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 23.88万 - 项目类别: